Search Tag: breast cancer diagnosis
2025 01 Jul
Breast cancer, the most prevalent malignancy in women worldwide, is categorised into four molecular subtypes based on receptor expression: luminal A, luminal B, HER2-enriched and triple-negative breast cancer (TNBC). These classifications guide therapeutic decisions and impact prognosis. Conventional methods of determining subtypes rely on biopsy-based...Read more
2025 01 Jul
Breast cancer, the most prevalent malignancy in women worldwide, is categorised into four molecular subtypes based on receptor expression: luminal A, luminal B, HER2-enriched and triple-negative breast cancer (TNBC). These classifications guide therapeutic decisions and impact prognosis. Conventional methods of determining subtypes rely on biopsy-based...Read more
2025 15 Jun
Breast cancer remains the most commonly diagnosed cancer among women worldwide. While mortality rates have declined due to better treatments and early detection, mammography continues to play a central role in reducing breast cancer deaths. Despite its value, mammography has well-documented limitations, particularly in women with dense breast...Read more
2025 25 May
Breast cancer continues to be one of the most prevalent and deadly diseases affecting women globally. Early detection remains crucial, and mammography has long been the cornerstone of breast cancer screening programmes. However, mammographic interpretation is susceptible to high false-positive and false-negative rates, particularly in women with...Read more
2025 25 May
Breast cancer continues to be one of the most prevalent and deadly diseases affecting women globally. Early detection remains crucial, and mammography has long been the cornerstone of breast cancer screening programmes. However, mammographic interpretation is susceptible to high false-positive and false-negative rates, particularly in women with...Read more
2025 25 May
Breast cancer continues to be one of the most prevalent and deadly diseases affecting women globally. Early detection remains crucial, and mammography has long been the cornerstone of breast cancer screening programmes. However, mammographic interpretation is susceptible to high false-positive and false-negative rates, particularly in women with...Read more
2025 17 Apr
Accurate distinction between benign and malignant breast lesions is critical for guiding patient management and avoiding unnecessary interventions. Traditional imaging methods, while effective for initial detection, often lack sufficient specificity, resulting in reliance on biopsies. Recent advances in MRI techniques offer new opportunities to improve...Read more
2025 25 Mar
The classification of human epidermal growth factor receptor 2 (HER2) expression in breast cancer has undergone significant transformation with the identification of HER2-low as a distinct category. Traditional assessment methods using immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are invasive, costly and time-consuming,...Read more
2025 25 Mar
The classification of human epidermal growth factor receptor 2 (HER2) expression in breast cancer has undergone significant transformation with the identification of HER2-low as a distinct category. Traditional assessment methods using immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are invasive, costly and time-consuming,...Read more
2024 07 Oct
Breast lesions present a challenge for accurate diagnosis, as it may be difficult to effectively differentiate benign from malignant types. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely recognised for its high sensitivity in evaluating these lesions. However, full DCE-MRI protocols can be time-consuming, leading to the...Read more
2024 02 Oct
Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more
2024 02 Oct
Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more
2024 26 Sep
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find CME On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/cmescience target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><aRead more
2023 02 Aug
A new study published in The Lancet Oncology showed that AI is safe to use in breast cancer detection and could assist doctors with finding cancer more effectively. The new research is believed to be the first-ever randomized control trial comparing AI-assisted breast cancer detection with detection solely performed by experienced humans. ...Read more
2023 02 Aug
A new study published in The Lancet Oncology showed that AI is safe to use in breast cancer detection and could assist doctors with finding cancer more effectively. The new research is believed to be the first-ever randomized control trial comparing AI-assisted breast cancer detection with detection solely performed by experienced humans. ...Read more
2019 30 Apr
Breast health leader will highlight expanding portfolio for breast conserving surgery Hologic, Inc. will showcase its growing breast surgery franchise, which includes products such as the new Trident® HD specimen radiography system, LOCalizer™ wire-free guidance system and the BioZorb® marker, in Booth #103 at the 20th Annual Meeting of...Read more
2019 26 Apr
Company expands breast specimen imaging portfolio and leadership in breast cancer diagnosis and care. Hologic, Inc. today announced global commercial availability of the Trident ® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during...Read more
2016 21 Jun
A combination of the decades-long practice of diagnosing illnesses by manually reviewing images under a microscope and artificial intelligence (AI), can help doctors improve accuracy of breast and other cancer diagnosis to a rate of 99.5 percent. A research team from Beth Israel Deaconess Medical Center (BIDMC) in Boston and Harvard Medical...Read more